English 
Business Engineering Co., Ltd. is pleased to announce that it has begun offering “BatchLine Lite MES,” a new pharmaceutical manufacturing record digitization tool from BatchLine Co., Ltd., from March 2025. By providing BatchLine, B-EN-G, which has knowledge of the pharmaceutical industry, will contribute to the digitization of manufacturing records in the industry. This will also help strengthen GMP compliance and improve the efficiency of manufacturing sites.
製薬業界では、従来の紙ベースの製造記録から生じる課題として、転記ミス、レビューの負担、記録紛失のリスク、監査対応の負担などが挙げられます。これらの問題を解決するためには、製造実行システム（MES）を導入し、製造記録を電子化することが正しいアプローチですが、導入コストや運用上の問題からMESを導入できない企業もあります。
こちらもお読みください： ニクセラ・ファーマ、金子潔のチーフ・コマーシャル・オフィサー就任を発表
B-EN-G had also received feedback from customers in the same industry that “computerization of manufacturing records is necessary, but the introduction of MES is a high hurdle in terms of the investment scale and securing of specialized personnel.” In light of this, BatchLine Lite MES, which places emphasis on the completeness of manufacturing records and compliance with regulations, is low-cost and has a proven track record overseas, and was determined to be the optimal solution to resolve these issues, and decided to begin offering it in Japan.
BatchLine is a company that provides manufacturing execution systems (MES) for the pharmaceutical industry. BatchLine’s MES solutions aim to help digitalize and streamline manufacturing processes while strengthening compliance. The company provides flexible and comprehensive solutions that meet the unique needs of the pharmaceutical industry, and has earned a high reputation among global pharmaceutical companies.
ソース PRタイムズ
日本語